Dr. Amit Bhalla, MD

With over 20 years of experience in the medical field, including 17 years of specialized knowledge in medicomarketing and KOL engagements, consistently recognized for excellence in performance and contributions to the success of the pharmaceutical industry. Strengths lie in the medical domain and related functions, demonstrated across various capacities. Postgraduate degree in MD Pharmacology provides a solid foundation for expertise.

Bhalla A and Kaushal S. Faropenem, a Stable and

Orally Bioavailable β-Lactam, to Counteract

Resistant Pathogens and Infectious Diseases. Adv

in Phar & Clin Tria 2023, 8(2): 000216.

Bhalla A and Kaushal S. Updates in

Gastroenterology: Acotiamide for Treatment of

Functional Dyspepsia. Bioequiv & Bioavailab Int J

2023, 7(1): 000195

Postpartum Haemorrhage (PPH) & Role of

Carbetocin: An Advanced Novel

TherapyPostpartum Haemorrhage (PPH) & Role of

Carbetocin: An Advanced Novel Therapy.

Novel Aspects on Pharmaceutical Research Vol. 2 ·

Certifications

Interests

Personal

May 20, 2023

Bhalla A. Acotiamide: a novel drug for the

treatment of patients with functional dyspepsia.

Int J Basic Clin Pharmacol 2017;6:1238-41.

As a Speaker for major brands, hold regular CMEs

across the domestic-India region markets.

Bhalla A. LA-5 [in: Abstracts: 40th Annual Meeting

of the American College of

ClinicalPharmacology; September 11-13, 2011;

Chicago, IL]. J Clin Pharmacol. 2011; 51(9):1327.

Research Paper presented in prize session in the

38th annual conference of Indian

Pharmacological Society held in Chennai in Dec.

2005.

Bhalla A. Advances in therapy of breast cancer:

overexpression and therapeutic implications of

targeting human epidermal growth factor

receptors.Int J Basic Clin Pharmacol

2019;8:1126-31.

Bhalla A. Clofarabine: a next-generation

deoxyadenosine analogue. Int J Basic Clin

Pharmacol 2018;7:1048-51